These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1655968)

  • 1. Current seroepidemiology of hepatitis A in Hong Kong.
    Chin KP; Lok AS; Wong LS; Lai CL; Wu PC
    J Med Virol; 1991 Jul; 34(3):191-3. PubMed ID: 1655968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing hepatitis A epidemiology among Hong Kong Chinese adolescents: what are the implications?
    Lee A; Cheng F; Lau L; Lo A; Fabb WE
    Public Health; 1999 Jul; 113(4):185-8. PubMed ID: 10483081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of hepatitis A virus in Japan.
    Taylor-Wiedeman J; Moritsugu Y; Miyamura K; Yamazaki S
    Jpn J Med Sci Biol; 1987 Jun; 40(3):119-30. PubMed ID: 2832647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The seroepidemiology of hepatitis A and B in a Japanese town.
    Akbar SM; Onji M; Kanaoka M; Horiike N; Michitaka K; Masumoto T; Nonaka T; Kanda K; Kajino K; Kumamoto I
    Asia Pac J Public Health; 1992-1993; 6(2):26-9. PubMed ID: 1339221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period.
    Furusyo N; Hayashi J; Sawayama Y; Kawakami Y; Kishihara Y; Kashiwagi S
    Am J Trop Med Hyg; 1998 Nov; 59(5):693-8. PubMed ID: 9840583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing seroepidemiology of hepatitis A virus infection in Taiwan.
    Hsu HY; Chang MH; Chen DS; Lee CY; Sung JL
    J Med Virol; 1985 Dec; 17(4):297-301. PubMed ID: 3001219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A and B infections in transfusion-dependent thalassaemia from endemic areas.
    Li AM; Chang WK
    J Paediatr Child Health; 1991 Aug; 27(4):228-31. PubMed ID: 1958422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis A, B and C seroprevalence in Pakistan.
    Agboatwalla M; Isomura S; Miyake K; Yamashita T; Morishita T; Akram DS
    Indian J Pediatr; 1994; 61(5):545-9. PubMed ID: 7538098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis A sero-epidemiology in Singapore: a changing pattern.
    Yap I; Guan R
    Trans R Soc Trop Med Hyg; 1993; 87(1):22-3. PubMed ID: 8385369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of hepatitis A in Asia and experience with the HAV vaccine in Hong Kong.
    Sung JJ
    J Viral Hepat; 2000 May; 7 Suppl 1():27-8. PubMed ID: 10866842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies against hepatitis A virus, hepatitis B virus, and Treponema pallidum in Mauritius.
    Schwarz TF; Kam CC; Min GL; Jilg W; Wilske B; Gürtler L; Deinhardt F
    Scand J Infect Dis; 1991; 23(5):535-41. PubMed ID: 1662829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis A and hepatitis B seroprevalence in 4 centers in Brazil].
    Clemens SA; da Fonseca JC; Azevedo T; Cavalcanti A; Silveira TR; Castilho MC; Clemens R
    Rev Soc Bras Med Trop; 2000; 33(1):1-10. PubMed ID: 10881112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between changing of anti-HAV in population and prevalence of hepatitis A].
    Li L
    Zhonghua Yu Fang Yi Xue Za Zhi; 1989 May; 23(3):139-40. PubMed ID: 2555117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers, in Goiania, Brazil.
    Queiróz DA; Cardoso DD; Martelli CM; Martins RM; Porto SO; Borges AM; Azevedo MS; Daher RR
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):427-33. PubMed ID: 8729753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal.
    Sawayama Y; Hayashi J; Ariyama I; Furusyo N; Kawasaki T; Kawasaki M; Itoh K; Acharya GP; Kashiwagi S
    J Epidemiol; 1999 Nov; 9(5):350-4. PubMed ID: 10616269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current prevalence of hepatitis B, A and C in a healthy Spanish population. A seroepidemiological study.
    Dal-Ré R; Aguilar L; Coronel P
    Infection; 1991; 19(6):409-13. PubMed ID: 1726163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A virus infection in Taipei City in 1989.
    Tzen KT; Chang MH; Tsen YJ; Lee CY; Chen DS
    J Formos Med Assoc; 1991 Feb; 90(2):138-40. PubMed ID: 1678406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Seroepidemiologic study of the prevalence of anti-HAV antibodies in children in Rome].
    Catania S; Ajassa C; Tzantzoglou S; Bellagamba R; Berardelli G; Catania N
    Riv Eur Sci Med Farmacol; 1996; 18(1):7-9. PubMed ID: 8766776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.